CSFZX
Price
$59.99
Change
+$0.58 (+0.98%)
Updated
Jun 12 closing price
Net Assets
2.28B
RRSRX
Price
$33.01
Change
+$0.35 (+1.07%)
Updated
Jun 12 closing price
Net Assets
413.02M
Interact to see
Advertisement

CSFZX vs RRSRX

Header iconCSFZX vs RRSRX Comparison
Open Charts CSFZX vs RRSRXBanner chart's image
CSFZX vs RRSRX Comparison Chart in %
View a ticker or compare two or three
VS
CSFZX vs. RRSRX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSFZX is a Buy and RRSRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSFZX has more cash in the bank: 2.28B vs. RRSRX (413M). CSFZX pays higher dividends than RRSRX: CSFZX (3.24) vs RRSRX (2.99). CSFZX was incepted earlier than RRSRX: CSFZX (12 years) vs RRSRX (10 years). RRSRX (1.02) is less costly to investors than CSFZX (0.84). RRSRX is a more actively managed with annual turnover of: 67.00 vs. CSFZX (57.00). CSFZX (0) and RRSRX (0) have matching initial minimum investment requirements. CSFZX annual gain was more profitable for investors over the last year : 13.15 vs. RRSRX (12.44). CSFZX return over 5 years is better than : 8.00 vs. RRSRX (-0.52).
CSFZXRRSRXCSFZX / RRSRX
Total Expense Ratio0.840.9291%
Annual Report Gross Expense Ratio0.841.0282%
Fund Existence12 years10 years-
Gain YTD9.97310.13498%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.28B413M553%
Annual Yield % from dividends3.242.99109%
Returns for 1 year13.1512.44106%
Returns for 3 years31.9530.59104%
Returns for 5 years8.00-0.52-1,538%
Returns for 10 years60.6623.69256%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPN67.712.52
+3.87%
Global Payments
RCUS23.800.50
+2.15%
Arcus Biosciences
FET52.960.57
+1.09%
Forum Energy Technologies
PEPG1.47-0.04
-2.65%
PepGen
FBLG0.93-0.03
-3.42%
FibroBiologics Inc.